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In Brief
The podocyte forms the most outer and
essential part of the renal filter and
restricts the passage of proteins from
blood to urine. Rinschen et al. combine
deep proteomic and transcriptomic data
with protein dynamics from native mouse
podocytes to reveal insights into
podocyte biology and to identify
candidate disease genes.
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Damage to and loss of glomerular podocytes has
been identifiedas theculprit lesion inprogressive kid-
ney diseases. Here, we combinemass spectrometry-
based proteomics with mRNA sequencing, bioinfor-
matics, and hypothesis-driven studies to provide a
comprehensive and quantitative map of mammalian
podocytes that identifies unanticipated signaling
pathways. Comparison of the in vivo datasets with
proteomics data from podocyte cell cultures showed
a limited value of available cell culture models. More-
over, in vivo stable isotope labeling by amino acids
uncovered surprisingly rapid synthesis of mito-
chondrial proteins under steady-state conditionsCe
This is an open access article under the CC BY-Nthat was perturbed under autophagy-deficient, dis-
ease-susceptible conditions. Integration of acquired
omics dimensions suggested FARP1 as a candidate
essential for podocyte function, which could be sub-
stantiated by genetic analysis in humans and knock-
downexperiments in zebrafish. Thiswork exemplifies
how the integration ofmulti-omics datasets can iden-
tify a framework of cell-type-specific features rele-
vant for organ health and disease.
INTRODUCTION
Diseases involving glomeruli, the filtration units of the kidney, are
a leading cause of chronic kidney disease (CKD), which affects
approximately 15%of all Americans (Meguid El Nahas and Bello,ll Reports 23, 2495–2508, May 22, 2018 ª 2018 The Authors. 2495
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2005; CDC) and substantially increases cardiovascular events.
Despite recent advances in the understanding of glomerular
biology, treatment of these disorders has remained extraordi-
narily challenging in many cases. The podocyte is a postmitotic,
neuron-like shaped epithelial cell with limited capacity for self-
renewal. Podocytes are essential to maintain a physiological
blood-urine barrier (Pavensta¨dt et al., 2003), and deterioration
of podocyte function and subsequent proteinuria are critical ac-
celerators of renal functional decline in disease states. Because
of considerable metabolic and mechanical stress, the podocyte
needs tomaintain its proteome—a prerequisite tomaintain its ar-
chitecture, cytoskeletal integrity, signal transduction, and meta-
bolic function. Interference with any of these functions—for
instance, as an inherited gene defect in humans (Boute et al.,
2000; Kaplan et al., 2000; Kestila¨ et al., 1998; Reiser et al.,
2005)—leads to proteinuria, podocyte loss, glomerular scarring
and, ultimately, chronic kidney disease.
Despite recent progress in the understanding of genetics and
signaling of proteinuric kidney disease, the molecular identity
of the podocyte is not defined, and it is unclear how its func-
tion could be targeted therapeutically. Abundant information
regarding podocyte mRNA expression patterns has been gath-
ered recently (Brunskill et al., 2011; Fu et al., 2016; Kann et al.,
2015), and integrative genomic studies have enormous potential
in classifying human podocyte disease and pathophysiology
(Hodgin et al., 2013; Ju et al., 2012; Sampson et al., 2015;
Susztak, 2014). However, several studies from different fields
found that absolute abundances of mRNA and protein abun-
dances correlate only moderately. Indeed, transcript levels can
only explain one- to two-thirds of protein levels, underlining the
importance of post-transcriptional control (Liu et al., 2016; Vogel
andMarcotte, 2012). In recent years, it became feasible to inves-
tigate the entity of proteins, the proteome, at an unprecedented
depth (Mann et al., 2013). As a result, proteins can be resolved
and quantified relatively and absolutely, culminating in a near-
comprehensive mass spectrometry-based expression map of
the human proteome (Kim et al., 2014; Wilhelm et al., 2014). In
addition, in vivo stable amino acid isotope labeling strategies
opened new avenues for the quantification of protein dynamics
when used in pulse experiments (Kr€uger et al., 2008; Savas
et al., 2012; Toyama et al., 2013). The aim of this study was to
generate a quantitative and integrative map of the podocyte pro-
teome, both static and dynamic, and its transcriptome to gain
novel and unbiased insights into podocyte biology. To demon-
strate the applications of this ‘‘atlas,’’ we conducted orthogonal
hypothesis-driven studies that supported the presence of unan-
ticipated molecular mechanisms maintaining podocyte protein
homeostasis and function.
RESULTS
Absolute Quantification of the Native Podocyte
Proteome
GFP-positive mouse podocytes and tomato-positive non-podo-
cyte glomerular cells were isolated from native glomeruli of an
hNPHS2Cre*mT/mG mouse using fluorescence-activated cell
sorting (FACS) (Boerries et al., 2013). Podocytes expressed
GFP, whereas all other viable glomerular non-podocyte cells ex-2496 Cell Reports 23, 2495–2508, May 22, 2018pressed tomato red fluorescent protein (Figure 1A). A work flow
for ‘‘deep mapping’’ of transcriptome, proteome, and proteome
dynamics was applied to both podocytes and non-podocytes
(Kulak et al., 2014). Quality control of the dataset demonstrated
a clear separation between both samples (Figure S1). This
approach identified, in total, more than 9,000 different proteins
(Tables S1 and S2). We performed absolute quantification of
6,979 proteins using the intensity-based absolute quantification
(iBAQ) approach (Table S2). This proteomics parameter is
relative to copy numbers in a given sample (Kohli et al., 2014;
Schwanha¨usser et al., 2011). Cytoskeletal proteins were highly
represented in the dataset (Figure 1A). The dynamic range of
the podocyte proteome copy numbers comprises seven orders
of magnitude (Figure 1B). We mapped genes associated with
focal segmental glomerular sclerosis or hereditary nephrotic
syndrome on this dataset (Figure 1C; top 10 genes in Figure 1D;
Bierzynska et al., 2015). These ‘‘disease-associated genes,’’
although only comprising 35 of 7,000 (0.5%) absolutely quanti-
fied proteins, contributed approximately 4% of the podocyte
protein mass, with cytoskeletal proteins like Actn4 and Arhgdia
contributing most to this amount (Figure 1D). Several other
known podocyte genes (e.g., Trpc6) were identified but could
not be quantified because of their low abundance. To estimate
the absolute protein quantity based on the data and determine
protein concentrations or copy numbers per cell, we applied a
recently developed algorithm on our dataset (‘‘proteomic ruler’’)
(Wisniewski et al., 2014). This provides a starting point to
determine the stoichiometries of known protein complexes;
for example, the prominent transmembrane slit diaphragm
complex within native mouse podocytes, which comprises
podocin-Neph1-Nephrin-Fat1 with a copy number ratio of
10:2:1:0.5 (Figure 1E), indicating that podocin is by far the
most abundant slit diaphragm protein within podocytes (Gra-
hammer et al., 2013).
Integration of Deep Transcriptomic and Proteomics
Data
Protein abundance is determined by the rate of transcription but
also a result of protein stability and posttranslational processing.
To identify the determinants of podocyte protein copy number
abundance, we performed comparison with a transcriptomic
copy number analysis performed by mRNA sequencing. Our da-
taset was similar to previously published mRNA sequencing
(mRNA-seq) analyses but demonstrated a greater depth upon
analysis with the same parameters (Figure 2A; Table S3; Fig-
ure S2). Enrichment analyses demonstrated overrepresentation
of several known pathways enriched on mRNA levels, among
these extracellular matrix (ECM) synthesis and nephrin interac-
tions (Figure 2B; Figures S2E–S2I; Brunskill et al., 2011). To un-
ravel the correlation of transcriptomic data with proteomic data
as a whole, iBAQ data were correlated with the transcriptomic
(tpm) values, but the correlation was rather weak (Figure 2C).
The correlation was stronger for podocytes compared with
non-podocytes (Figure 2D). We checked which proteins were
specifically stabilized or destabilized posttranscriptionally using
2D enrichment (Cox and Mann, 2012). This algorithm can be
used to visualize statistically significant distributions of protein
annotations in a 2D space between different ‘‘omics’’ datasets
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Figure 1. Absolute Quantification of the
Native Podocyte Proteome
(A) Panther term analysis of expressed genes and
absolute copy numbers (intensity-based absolute
quantification [iBAQ]). iBAQ values corresponding
to the number of protein copies (green) and the
number of different proteins (black) are plotted.
(B) Overview of the dynamic range of the podocyte
proteome absolutely quantified using iBAQ.
(C) Expression of proteins encoded by genes
causing hereditary nephrotic syndrome and focal
segmental glomerulosclerosis in podocytes ac-
cording to Bierzynska et al. 2015).
(D) Abundance of the 10 most abundant proteins.
(E) Application of the proteomic ruler to detect
protein copy numbers of transmembrane proteins
of the slit diaphragm complex (Wisniewski et al.,
2014). Calculated numbers of protein copies per
cell are depicted.(Cox and Mann, 2012). The analysis revealed that ECM protein
expression was decreased as expected by the respective
mRNA expression, which would be expected because of loss
of podocyte-produced ECM proteins excreted as part of the
glomerular basement membrane assembly (Figure 2E, blue).
Proteins involved in controlling metabolism were largely stabi-
lized (Figure 2E, magenta, green). These proteins included
glycolysis gene products and proteins involved in amino acid
biosynthesis.
Determination of Podocyte-Enriched Proteins
Most of the genes mutated in genetic forms of proteinuria or
nephrotic syndrome encode for podocyte-enriched genes.
Therefore, we next analyzed whether we could expand the list
of known podocyte-enriched proteins compared with other
glomerular cells. Using stringent statistical cutoff values for
quantification, we found 551 podocyte-enriched proteins (Fig-
ure 3A; Table S2); among these were many gene products
currently known to be associated with hereditary nephrotic syn-
drome (Sadowski et al., 2015). Figures S3 and S4A depict stan-
dardized stainings of 190 proteins that have a ‘‘medium’’ or
‘‘high’’ staining intensity in the human protein atlas (Uhle´n
et al., 2015). A systematic Medline search of these 190 proteins
revealed that the majority were not explicitly linked to podocytesCell R(Table S4). We performed statistical
enrichment for overrepresentation of pro-
tein domains in all 551 proteins enriched
in podocytes (Figure 3B). Significantly
enriched protein domains were Fn3 and
immunoglobulin G (IgG)-like domains
(e.g., in Nephrin), PDZ domains (e.g., in
ezrin and Par-3), i-set domains (e.g., in
nephrin and VCAM/NCAM), CH domain
(e.g., in actinin-4), and FERM domain pro-
teins (e.g., in ezrin) or tetraspanins (e.g.,
CD151). On a global level, podocyte-spe-
cific proteins were significantly reduced
for mitochondria as well as RNA andDNA binding proteins (Figure 3C) and enriched for signaling re-
ceptors, cytoskeleton-associated proteins, GTPase-associated
proteins, membrane proteins, and (phospho)lipid-modifying
proteins (Figure 3D).
To demonstrate that this resource may be used to find essen-
tial podocyte proteins, we analyzed the effect of knockdown of
one candidate podocyte-enriched gene in Drosophila nephro-
cytes, an established model of podocyte function (Weavers
et al., 2009; Zhang et al., 2013). We knocked down Tsp26A,
the Drosophila homolog of TSP5 and TSP15, two newly identi-
fied podocyte-enriched proteins that are representatives of the
protein class of tetraspanins (Figure 3D). This resulted in signifi-
cantly decreased ANF-RFP uptake, indicating loss of filtration
function (Figure 3E). We also found overt alterations in nephro-
cyte ultrastructure (Figure 3F), proving the importance of the tet-
raspanin protein class for nephrocyte function.
Podocyte protein homeostasis largely depends on signaling
mediated via posttranslational modifications, such as phosphor-
ylation, ubiquitylation, acetylation, and proteolytic processing
(New et al., 2014). Pinpointing podocyte-specific signaling mol-
ecules could help us to understand podocyte physiology and
target podocyte signaling pharmacologically or genetically.
Table 1 summarizes unanticipated observations of signaling
molecules enriched in mouse podocytes; among these wereeports 23, 2495–2508, May 22, 2018 2497
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Figure 2. Integration of Deep Transcrip-
tomic and Proteomics Data
(A) Comparison of this and other recent tran-
scriptomic (tpm) studies using mRNA-seq. All da-
tasets were processed with the same bioinfor-
matics pipeline as indicated in the Experimental
Procedures.
(B) Reactome analysis of transcripts enriched in
podocytes (up) and de-enriched in podocytes
(down).
(C) Scatterplot demonstrating correlation between
proteomic (iBAQ) and (tpm) copy numbers in po-
docytes (Pearson’s R = 0.47, log(p) = 14.8). The
density of individual proteins is color-coded (blue,
high density; green, low density).
(D) 2D Uniprot keyword analysis of podocyte
transcript and protein copy numbers identifies
significantly changed Uniprot keywords with an
especially high increase in either omic dataset
(permutation-based FDR < 0.05). The dashed gray
line (y = x) indicates annotations equally repre-
sented in both omic datasets.
(E) Distribution of individual Uniprot keyword
members in the original scatterplot (analog to C).several druggable molecules. (For a full list of podocyte enriched
kinases, phosphatases, ubiquitin ligases, proteases, signaling
receptors, actin binding proteins and transcription factors, see
Table S5). We also mapped the 551 podocyte-enriched proteins
against known protein interaction databases to obtain a network
and central nodes among these podocyte-enriched proteins
(Cerami et al., 2010). The proteins RhoA, Actin, and Grb and
the nephrin-regulating kinase Src had most edges within these
networks (Figure S4B); all four have reported relevance for podo-
cyte biology (Harita et al., 2008; New et al., 2014; Schmieder
et al., 2004), suggesting a central role for these proteins.
Comparison of the DeepNative Podocyte Proteomewith
the Cultured Podocyte Proteome
We asked whether this unique obtained podocyte proteome
resource would help us to investigate the strengths and weak-2498 Cell Reports 23, 2495–2508, May 22, 2018nesses of in vitro immortalized podocyte
cell cultures, a commonly used tool in
podocyte research. To this end, we
compared the dataset with a similar, pre-
viously published deep quantitative pro-
teomic mapping of a mouse podocyte
cell line (Rinschen et al., 2016b). We could
identify 6,193 proteins in both samples,
representing a significant overlap be-
tween both samples (Figure S4C). Clus-
tering analysis of normalized expression
values revealed significant differences
between native podocytes and the
in vitro cell line irrespective of the differen-
tiation status (33C = undifferentiated or
37C = differentiated; Figure S4D). Clus-
tering analysis revealed eight major clus-
ters. Three clusters contained proteinswith high abundance in cell lines compared with the native podo-
cytes and were enriched for proteins related to the actin cyto-
skeleton, including stress fibers and focal adhesion proteins
(Figure 4A). Three clusters contained proteins with low abun-
dance in cell lines compared with the native podocytes (Fig-
ure 4B). These clusters were related to phospholipid metabolism
and tight junctions. Two clusters showed differences between
33C and 37C and native cells; these were, as expected
(Rinschen et al., 2016b), related to the cell cycle (Figure 4C).
Moreover, disease-causing proteins such as nephrin and podo-
cin or podocyte markers such as WT1 were not at all or only very
weakly expressed in podocytes in culture compared with the
in vivo dataset.
This comparison of podocyte proteomes from cell culture and
from native tissue suggested that podocyte cell cultures have an
increased abundance of stress fiber-associated proteins and
AC
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B Figure 3. Determination of Podocyte-En-
riched Proteins Uncovers Druggable Tar-
gets and Candidate Genes for Podocyte
Function
(A) Volcano plot of protein quantification of podo-
cytes over non-podocytes. The logarithmic fold
change of label-free quantification intensities
(LFQs) is plotted versus the negative decadic log-
arithm of the p value. 551 proteins pass the criteria
for significant podocyte enrichment (significance
analysis of microarrays [SAM] analysis, s0 = 1,
FDR = 0.01).
(B) Enrichment analysis of protein domains in
podocytes. Protein domains (PFAM and INTERPO
annotation) were tested for enrichment within the
podocyte-enriched proteins over the proteins
not significantly enriched. –log(p value) of every
significantly enriched protein domain is plotted
against fold enrichment. Fisher’s exact test,
FDR < 0.02.
(C) GO terms overrepresented in the 551 podo-
cyte-enriched proteins compared with non-podo-
cyte specific proteins. Fold enrichment of GO
terms representing molecular function (GOMF,
gray bars), cellular component (GOCC, black
bars), and biological process (GOBP, white bars).
All GO terms are statistically enriched in the data-
set compared with non-podocyte proteins. Fishers
exact test, FDR < 0.05.
(D) Significantly de-enriched GO terms in the 551
podocyte-specific proteins (the same statistical
criteria and color code as in C).
(E) CLSM micrographs of pericardial nephrocytes
at second larval stage. RNAi-mediated knockdown
of Tsp26A significantly reduced ANF-RFP (red)
uptake, suggesting that Tsp26A is required for
pericardial nephrocyte (green) function. The ANF-
RFP uptake is significantly reduced by the knock-
down of Tsp26A (p value < 0.05)
(F) Ultrastructural alteration of Tsp26A knockdown
nephrocytes. Arrows indicate nephrocyte cell
contacts.focal adhesions. We postulated that some of these differences
may have been a cell culture artefact because of the mechanical
properties of the plastic dish on which these cells were culti-
vated. As a proof of principle, we cultured podocytes on soft ma-
trix with an elastic modulus of 12 kPa and compared their prote-
ome with podocytes grown in plastic dishes (in the range of
gigapascals). This elastic modulus (‘‘stiffness’’) of 12 kPa is
similar to that of a skeletal muscle cell, a mechanically chal-
lenged cell (Gilbert et al., 2010; Janmey and Miller, 2011). Using
quantitative proteomics, we found vast differences in the podo-
cyte proteome depending on the matrix on which they were
grown (Figures S5A and S5B). On a global level, actin filament
proteins and stress fiber proteins were significantly depleted
by culturing podocytes on the ‘‘soft’’ matrix, which made them,
in this regard, ‘‘more similar’’ to the native podocyte (based on
the log2 ratio of podocyte/non-podocyte protein expression)
(Figure 4D). A similar picture arose when human podocytes
were cultured on soft matrices. The changes in the proteomewere larger (Figure S5), and the analysis confirmed again the
loss of stress fiber protein expression on the soft matrices
(Figure 4E; p and false discovery rate (FDR) < 0.05 in a Fisher’s
exact test).
Analysis of Podocyte Proteome Dynamics and
Integration with Deep Proteomics Mapping
To conclude, our data quantitatively describe expression levels
in the podocyte proteome. However, these data did not yet cover
an important, rather unexploited component of global proteosta-
sis regulation in vivo: the dynamic synthesis and turnover of pro-
teins. To approach this, we used a mouse model of in vivo stable
isotope labeling (Table S6). To this end, adult mice (10 weeks of
age) were fed for 1, 2, and 3 weeks with a diet exclusively con-
taining heavy isotope-labeled lysine. The incorporation of this
essential amino acid should correlate with the dynamic synthesis
rate (although these data do not strictly correlate with a protein
‘‘half-life’’ because of intracellular amino acid recycling (Kr€ugerCell Reports 23, 2495–2508, May 22, 2018 2499
Table 1. Examples of Podocyte-Enriched Kinases, Transcription Factors, and Potentially Druggable Targets
Gene Symbol Uniprot ID
Log2(Ratio),
(log(p)) Name Comment References
Csnk1g3 Q8C4X2 2.14 (2.84) casein kinase 1 gamma 3 an acidophilic S/T protein
kinase that is a candidate
for abundant acidophilic
phosphorylation on slit
diaphragm proteins
(Nephrin, Trpc6, and Cd2ap)
Rinschen et al., 2014,
2015b
Nek1 B7ZWK0 3.43 (3.61) serine/threonine protein
kinase Nek1
a protein kinase (STY)
responsible for ciliogenesis
Shalom et al., 2008
Mst4 Q99JT2; 2.89 (4.70) serine/threonine protein
kinase MST4
members of the canonical
hippo pathway, linked to
mechanotransduction and
apoptosis, druggable
Schwartzman et al., 2015,
Rinschen et al., 2017
Lats2 Q7TSJ6 3.25 (2.37) serine/threonine protein
kinase LATS2
Tead1 P30051 3.70 [1.83] transcriptional enhancer
factor TEF-1
Dach1 Q9QYB2 4.63 (4.22) dachshund homolog 1 a transcription factor strongly
enriched in podocytes
(comparable with WT1), GWAS
demonstrate association with GFR
Ko¨ttgen et al., 2010
Cblb B9EKI5;
Q3TTA7
4.10 (2.23) E3 ubiquitin-protein
ligase CBL-B
strongest enriched ubiquitin
ligase in podocytes, localizes in
immune cells and mediates the
expression of EGF receptors in a
protein complex with the recently
discovered podocin-associated
ubiquitin ligase Ubr4, potentially
druggable
Rinschen et al., 2016a,
Tong et al., 2014,
Wirnsberger et al., 2016
Npr3 P70180 4.89 (1.89) atrial natriuretic peptide
receptor 3
mediates ANP signaling via cGMP,
confirmation of in vitro and
in vivo studies
Rinschen et al., 2016b,
Staffel et al., 2016
Npr1 P18293 2.38 (3.70) atrial natriuretic peptide
receptor 1
Pth1r P41593 6.19 (2.78) PTH receptor mediates Pth signaling via cAMP,
confirmation of in vitro studies
Endlich and Endlich, 2002
Ifngr1 P15261 3.85 (1.86) interferon gamma
receptor 1
confirmation of in vitro and in vivo
study, druggable
Gurkan et al., 2013
Mertk Q60805 4.83 (4.36) tyrosine protein kinase Mer most enriched tyrosine kinase
family, involved in cancer and
development, druggable
Lee-Sherick et al., 2015,
Zhang et al., 2014,
Fleuren et al., 2014
Tyro3 P55144 4.30 (3.76) tyrosine protein kinase
receptor TYRO3
Axl Q6PE80 4.02 (3.32) Tyrosine-protein kinase
receptor UFO
Log2(Ratio) is defined as log2(LFQ in podocytes)/(LFQ in non-podocytes) and is ameasurement of podocyte enrichment. Table S5 gives an overview of
each class of the annotated signaling molecules. GWAS, genome-wide association study; EGF, epidermal growth factor; cAMP, cyclic AMP; GFR,
glomerular filtration rate; cGMP, cyclic GMP; PTH, parathyroid hormone; atrial natriuretic peptide (ANP).et al., 2008)). Still, proteins synthesized rapidly should exhibit a
high heavy amino acid incorporation rate (and a high heavy/light
[H/L] ratio), whereas stable, ‘‘long-lived’’ proteins with slow
translation should have a lower incorporation rate (Savas et al.,
2012). To see which proteins incorporate isotopes at a similar
speed, we performed hierarchical clustering of H/L ratios over
the labeling time course. This analysis revealed four major
clusters of proteins (Figures 5A and 5B). Gene ontology (GO)
term analysis of these four clusters revealed that endoplasmic
reticulum (ER)-associated proteins (cluster 4) were particular
‘‘dynamic’’ compared with the nuclear proteins, in particular his-2500 Cell Reports 23, 2495–2508, May 22, 2018tones (cluster 1), which only showedminimal increases in the H/L
ratio (Figure 5C), consistent with previous studies (Toyama et al.,
2013). There was almost no correlation between iBAQ values
and H/L ratios (correlation coefficient [R2] = 0.01) (Fig. S6A).
When comparing podocyte H/L ratios with those of co-sorted
non-podocyte cells, we observed that podocyte proteins incor-
porated more slowly than the parallel sorted non-podocyte cells
(Figure 5D). 2D GO analysis revealed that cytoskeletal and mito-
chondrial proteins had a particularly high protein turnover in po-
docytes compared with non-podocyte cells (Figure 5E). We also
analyzed an intact whole kidney protein sample from an
AC
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Figure 4. Comparison of the Deep Native (Isolated from Living Mice) and Cultured Podocyte Proteome Enables Functional Analysis of Cell
Culture-Induced Proteome Artefacts
(A) Protein clusters were defined based on normalized intensities as depicted in Figure S4C–D. Shown are clusters that have a higher intensity in cultured po-
docytes compared with the native podocyte proteome. Distance to the mean is color-coded in each cluster. GO terms significantly overrepresented in each
cluster are depicted (Fishers exact test, p values corrected with FDR < 0.05).
(B) Three clusters have a lower intensity (and abundance) in the podocyte proteome compared with the cultured podocyte proteome. GO terms significantly
overrepresented in each cluster are depicted.
(C) Two clusters have different intensities in undifferentiated and differentiated podocytes.
(D) Mouse podocytes were seeded onmatrices with 12 kPa, and the proteome was compared with control cell culture dishes. See Figure S5 for details regarding
the dataset. The 2D GO enrichment score of fold change on soft matrix (log2 12 kPa/control) cell culture is plotted against the score for podocyte-enrichment
(log2(podocyte/non-podocyte)) (Figure 3). The data demonstrate a significant decrease of stress fiber proteins under both conditions (soft versus stiff matrix and
native podocyte versus non-podocyte). Significantly changed terms are plotted (FDR < 0.05)
(E) Human podocytes were seeded onmatrices with 12 kPa, and the proteome was compared with control cell culture dishes. See Figure S5 for details regarding
the dataset.
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Figure 5. Integration of Podocyte Prote-
ome Dynamics and Deep Proteomics Map-
ping Demonstrate Proteostatic Podocyte
Features
(A) Adult mice were fed a diet in which lysine was
substituted with stable isotope-labeled 13C6 lysine
for the indicated times, resulting in a gradual sub-
stitution of the endogenous lysine 12C6 lysine (light
lysine) with 13C6 lysine (heavy lysine). Mean H/L
ratios of more than 4 animals are depicted.
(B) Hierarchical clustering (maximum distance) of
mean protein H/L ratios was performed, and four
major row clusters were defined.
(C) GO enrichment of GOMF (black), GOCC (gray),
and GOBP (white) terms (Fishers exact test, cor-
rected FDR < 0.05) in each of the 4 major clusters
was performed.
(D) Scatterplot of H/L ratios between podocytes
and non-podocyte cells demonstrates that podo-
cytes have a generally slower incorporation of
stable isotope-labeled lysine.
(E) 2D GO enrichment analysis of H/L ratios of
significantly regulated Uniprot keywords of podo-
cytes and non-podocyte cells (FDR < 0.05).
(F) Scatterplot of corrected H/L ratios between
podocytes and non-podocytes.
(G) Cumulative histogram of corrected H/L ratios
for cytoskeletal and mitochondrial proteins. When
H/L ratios are corrected with absolute protein
abundance (Dotproduct, see Experimental Pro-
cedures for details), mitochondrial proteins have
a similar corrected ratio compared with all other
proteins.
(H) H/L ratios in podocytes from control mice
plotted against H/L ratios in podocytes in
Nphs2.Cre:Atg5 fl/fl (ATG5ko) mice. ATP5o is a
subunit of the mitochondrial ATP synthase.
(I) H/L ratios in non-podocytes from control mice
plotted against H/L ratios in non-podocytes of
(ATG5ko) mice.independent parallel study (Figures S6B and S6C), confirming
that mitochondrial proteins were incorporated relatively faster
in podocytes compared with the whole kidney. However, this
comparison did not respect overall protein amounts, and protein
amounts are significantly different between podocytes and non-
podocytes (Figure 3A). Thus, a mere relative incorporation rate is
not sufficient to estimate how much ‘‘energy’’ a podocyte
spends to maintain the specific protein compared with another
cell type; this would crucially depend on the copy numbers
and, as an ancillary factor, on the size of the protein. Therefore,
we corrected the incorporation rates by total protein abundance
and size (Experimental Procedures). The analysis revealed that
actin-binding proteins and cytoskeletal proteins incorporated
heavy amino acids markedly stronger (Figure 5F). Interestingly,
four proteins associated with hereditary podocyte disease
were in the upper quartile of most dynamic proteins, among2502 Cell Reports 23, 2495–2508, May 22, 2018these podocin (Nphs2), Cd2ap (Cd2ap),
and actinin-4 (Actn4) (Figures 5F and 5G)
and Magi2 (Bierzynska et al., 2016;
Figure 5F). The number of amino acidsincorporated into mitochondrial proteins was not different in po-
docytes compared with non-podocytes (Figure 5G), which could
be explained by low mitochondrial mass (Figure 3) but high turn-
over of these organelles (Figure 5B). These data indicate that
some of the podocyte’s unique proteotypic features are partially
compensated by increased protein synthesis and, potentially,
proteostasis.
An unexpected finding was that podocytes have high mito-
chondrial protein synthesis but an overall low protein copy num-
ber of mitochondrial proteins. We asked whether this balance
would tilt further when genetic manipulation of podocyte proteo-
stasis was performed. We performed quantitative pulse labeling
of amino acids in young control mice as well as in young mice
with podocyte-specific knockout of autophagy-related 5 (ATG5
podocyte specific knockout [pKO]), a major positive regulator
of autophagy in general and especially in podocytes (Hartleben
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EC D
F
G
Figure 6. Identification of Candidates for Human Nephrotic Syndrome Disease-Causing Genes
(A) Clustering analysis (t-SNE) of 6,700 proteins for which absolute protein expression, relative protein expression, mRNA expression, and tissue-specific mRNA
expression were available.
(B) Heatmap analysis of expression of disease genes and one previously unreported candidate gene, FARP1, as well as five candidates from a previous study
(Yu et al., 2016).
(legend continued on next page)
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et al., 2010; Table S6). The ATG5 pKO allele makes podocytes
extremely susceptible to damage (Hartleben et al., 2010). We
observed that ATG5 knockout podocytes had a significantly
lower incorporation of endoplasmic reticulum proteins, a finding
expected from a defect in autophagy, and, surprisingly a signif-
icantly higher incorporation of mitochondrial proteins compared
with control podocytes (Figure 5H). This was consistent with
2D GO enrichment time points after different time points
(Figures S6D and S6E). Isotope-labeled lysine incorporation in
non-podocyte cells was not changed dramatically across both
conditions (Figure 5I). In conclusion, these data delineate a spe-
cific perturbation in isotope incorporation in podocytes, specif-
ically affecting mitochondria.
Multi-omics Integration Reveals Candidate Genes for
Podocyte Function in Humans
Finally, we asked whether the integration of genomic and prote-
omic analyses could reveal candidate genes essential for podo-
cyte function. To this end, we performed clustering analysis of
z-normalized relative mRNA expression levels, relative protein
expression levels, absolute protein expression levels, and tissue
specificity of podocyte mRNA levels. We found that disease-
associated genes in slit diaphragm and actin-related processes
were largely defined by very high Z scores in all of the four
parameters and clustered close to each other (Figures 6A and
6B). Subsequently, we defined 280 genes based on each of
these criteria (Table S7) and screened exome sequencing of
430 families with hereditary nephrotic syndrome for homozygous
mutations in these genes. As a result, we identified a homozy-
gous mutation in the gene FARP1 in one family with nephrotic
syndrome (Table S7). This candidate gene, and the genes iden-
tified in a recent population-based study (Yu et al., 2016), clus-
tered close to known disease genes (Figure 6A), and all shared
high Z scores in at least three of the four parameters analyzed
(Figure 6B). From a genetic perspective, several factors suggest
potential pathogenicity of the identified allele: the mutation
affects amino acid residues that are highly conserved among
orthologs across evolution; in a control database of 80,000 pre-
dominantly healthy individuals (Exome Aggregation Consortium
[ExAC]), the minor allele frequency of either allele is below
0.01%, and it has not been reported in the homozygous state;
and the allele segregates with the affect status within the family
(Figure 6C). The mutated residues were highly conserved and
the mutation localized in a functional PH domain of the protein,
and histology and electron microscopy showed clear signs of
podocyte dysfunction within the affected individual (Figures
S7A–S7E). A second patient with previously non-identified
FARP1 variants was identified in a second cohort of 700 patients
with nephrotic syndrome (patient was heterozygous for T789M,
and c.-20T > A); however, it was unclear whether the alleles(C) Sanger sequencing of the respective regions of FARP1 demonstrates segreg
(D and E) Embryonic and renal expression profile of the candidate protein Farp1
(D) Farp1 shows high expression in metanephric glomerular precursors and rea
pulmonary epithelial structures in embryonic day 14.5 (E14.5) mouse embryos.
(E) Farp1 expression is maintained in murine P1 kidneys in glomeruli.
(F) Knockdown of farp1 in zebrafish induces edema and pericardial effusion (arro
(G) Overview of insights into podocyte biology obtained from this study.
2504 Cell Reports 23, 2495–2508, May 22, 2018segregated with the phenotype because the DNA of family mem-
bers could not be sequenced. The FARP1 gene newly identified
in this study also localized predominantly to glomeruli and their
precursors in development and kidneys of newborn mice (Fig-
ures 6D and 6E). In addition, knockdown of the farp1 mRNA in
zebrafish larvae resulted in a phenotype of pericardial edema
as well as proteinuria, indicating loss of glomerular barrier
function in D. rerio (Figure 6; Figures S7F and S7G).
DISCUSSION
Postmitotic specialized cell types, such as neurons or podo-
cytes, are particularly vulnerable to age-dependent degenera-
tion. In fact, the podocyte has emerged as a central gatekeeper
to prevent proteinuria and renal failure, two unmet and frequent
clinical symptoms associated with dramatically increased car-
diovascular risk. Interrogation of individual cell types at multiple
omics levels can yield insights into both essential molecular
components and preventive strategies. Here we gained a
near-comprehensive view of the static and dynamic podocyte
proteome and transcriptome by applying recently developed
technologies (Kulak et al., 2014). Single-cell podocyte sorting
previously enabled only incomplete in vivo analysis of the podo-
cyte proteome (Boerries et al., 2013; Rinschen et al., 2015a,
2016a). At least 10,000 proteins are suggested to be expressed
in a cultured cell line (Kulak et al., 2014; Mann et al., 2013;
Nagaraj et al., 2011), and a similar number of proteins has
been shown to be expressed in native neurons (Sharma et al.,
2015). Here we demonstrate that such a comprehensive atlas
of protein and mRNA expression datasets now allows distilling
molecular characteristic features of podocytes, ultimately up to
the prediction of candidate genes associated with human dis-
ease. Figure 6G gives an overview of the findings in this study.
Podocytes express a high abundance of actin-binding pro-
teins and proteins known to be localizing to the leading edge
of the cell (Figures 1, 2, and 3; Table S5). Expressed in simplified
terms, many of these proteins oppose the formation of stress
fibers by promoting actin branching to promote a ‘‘motile’’
phenotype (Higgs and Pollard, 2001). The leading edge is a
long-established model to study the cell biology of podocyte
foot processes, and eventual slit diaphragm signaling (Garg
and Holzman, 2012; Garg et al., 2010; Moeller et al., 2004),
and based on these global proteomic data, this paradigm could
be further expanded. This study discovered signaling molecules
enriched in podocytes, which may be directly translated to novel
experimental studies. Several of the proteins, but by far not all of
them, have already been studied in podocytes and have been
linked in part by dramatic phenotypes in conditional and targeted
mouse models (e.g., protein kinase C) (Huber et al., 2009) or
human patients (e.g., MAGI2; Bierzynska et al., 2016). Aation of the mutated alleles with the affected status in family F1138 (FARP1).
by in situ hybridization.
dily detectable expression in neuronal tissues and, to some extent, in other
w), indicating proteinuria and podocyte dysfunction.
significant fraction of these proteins, however, has not been
extensively studied and will require further consideration (Table
1; Table S4); for instance, specific members of the tetraspanin
family, which were confirmed in Drosophila nephrocyte studies
as highly conserved functional regulators of filtering cells (Sachs
et al., 2012; Figure 3).
In addition to using these data as a resource, one may also
delineate ‘‘systems-level’’ features of molecular podocyte iden-
tity. To demonstrate this approach in principle, we delineated dif-
ferences to the proteome of a commonly used immortalized
mouse podocyte cell culture line (Rinschen et al., 2016b).
Cultured podocytes are widely used to investigate podocyte
damage and serve as a model to study the regulation of the
cytoskeleton and many other aspects of podocyte biology (Lee
et al., 2015a; Shankland, 2006; Yu et al., 2013). Surprisingly,
the systems-level comparison of proteome-wide expression
data (Figure 4) revealed that proteins involved in stress fiber for-
mation are among the strongest dysregulated processes in cell
cultures, a finding that could be caused by stiffness of the cell
culture dish (Gilbert et al., 2010). As a proof-of-principle experi-
ment, the cultivation of either human or mouse podocyte cells on
soft matrices resulted in a major shift in the proteome, which
partly reduced this actin-related cell culture artefact (Figure 4).
This is consistent with observations that podocytes strongly
react to other mechanical cues, such as hydrostatic pressure
(Kriz and Lemley, 2015), stretch (Durvasula et al., 2004; Kim
et al., 2013; Petermann et al., 2005), or membrane curvature
(Inoue and Ishibe, 2015), in vitro and in vivo (Hu et al., 2017;
Rinschen et al., 2017). Cultivation on soft matrices does not,
however, increase the expression of podocyte-specific actin
binders or podocyte membrane proteins, which are only mini-
mally expressed under both conditions.
Mitochondrial proteins are rarely expressed in podocytes
(Figure 3), but the synthesis of these proteins (as measured by
in vivo stable isotope pulse labeling) is faster than in non-podo-
cytes. Therefore, the podocyte has an overall low abundance of
mitochondrial proteins but high mitochondrial resynthesis and,
assuming a steady-state equilibrium, also turnover. This may
be a surrogate readout of predominant mitochondrial degrada-
tion (e.g., by mitophagy) in podocytes compared with other
glomerular cell types. Consistently, podocytes show protein-
level enrichment for the ubiquitin ligase Parkin2 (log2 fold
change 2.33), a key molecule controlling mitophagy (Narendra
et al., 2008; Table S2). Interestingly, when knocking out ATG5,
a protein essential for autophagy (Hartleben et al., 2010), the
podocyte reacts, when still intact and functional, with even
further increased synthesis of mitochondrial proteins (Figure 5H).
One could speculate that this finding may be caused by
increased alternative autophagy and mitophagy, a process
significantly increased in the absence of ATG5 (Hirota et al.,
2015). In fact, mediators of alternative autophagy (e.g., Rab9
and Becn1) are abundantly expressed in podocytes but not
significantly enriched (Lee et al., 2015b; Table S2). Although
these findings need further corroboration, these data demon-
strate the feasibility to dissolve dynamic proteostatic shifts
in vivo by integrating dynamic and static protein quantifications
and cutting through the various dimensions of podocyte
proteostasis.In summary, these data provide a unique resource and
starting point for the next level of systematic understanding of
podocyte identity, function, and glomerular disease mecha-
nisms, including a systems view of podocyte proteome dy-
namics (Figure 6G). Using a multidimensional analysis, we
showed that a majority of podocyte disease genes (mainly slit
diaphragm- and actin-related genes) have rather high relative
and absolute protein expression as well as podocyte-specific
mRNA expression (Figures 6A and 6B). This opens the door for
a potential integrative ‘‘reverse genetic’’ approach to predict
functionally relevant candidate genes associated with human
podocyte diseases (Figure 6; Table S7) and prioritize them for
further functional testing, in particular when more advanced
bioinformatics methods are utilized and further data (e.g., tran-
scriptome data frompatient cohorts) are integrated. The concept
presented here will be advantageous for understanding cell-
type-specific function in health and disease.
EXPERIMENTAL PROCEDURES
Animals
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J mice were purchased from The Jack-
son Laboratory (Bar Harbour, Massachusetts, USA) (Muzumdar et al., 2007),
and Tg(NPHS2-cre)295Lbhmicewere a generous gift fromM.Mo¨ller (University
ofAachen,Aachen,Germany).UseofAtg5floxmicehasbeen reportedpreviously
(Hartleben et al., 2010). In general, Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J;
Tg(NPHS2-cre)295Lbh mice (for deep proteome, RNA-seq, and
pulsed in vivo stable isotope labeling experiments) as well as
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J; Tg(NPHS2-cre)295Lbh;Atg5flox/flox
mice (pulsed in vivo stable isotope labeling experiments) were on a mixed
genetic background (Sv129/C57Bl6/ICR). Breeding and genotyping was done
according to standard procedures. Mice were housed in an SPF facility with
free access to chow and water and a 12-hr day/night cycle. All animal
experiments were conducted according to the guidelines of the American
Physiological Society as well as the German law for the welfare of animals and
were approved by local authorities (Regierungspra¨sidium Freiburg X12/06J,
G11-38, and G11-34). Glomeruli and, subsequently, podocytes were isolated
using essential the same method as described previously (Boerries et al.,
2013). For details, see Glomerular Isolation and Podocyte Preparation in the
Supplemental Experimental Procedures.
Liquid Chromatography-Tandem Mass Spectrometry Acquistion
For details regarding sample preparation of native podocytes for proteomic
analysis, see the Supplemental Experimental Procedures. Analysis of peptides
was performed using a quadrupole-orbitrap mass spectrometer (Q Exactive
Plus, Thermo Scientific, Bremen) coupled to a nano-liquid chromatography
(nLC) device. The mass spectrometers were calibrated weekly. Briefly, pep-
tides were separated by nLC using a 4-hr gradient (flow rate, 200 nL/min). Pep-
tides were separated on an in-house packed 50-cm column with 1.7-mm C18
beads (Dr. Maisch). Ascending concentrations of buffer B (80% acetonitrile,
0.1% formic acid) over buffer A (0.1% formic acid) were used. Then peptides
were sprayed into the mass spectrometer by electron spray ionization. The
acquisition parameters for the mass spectrometer were as described previ-
ously (Bartram et al., 2016). 1E6 was the AGC target for MS1. The resolution
was 70,000 (mass range, 200–1200 mz1). Tandem mass spectrometry
(MS/MS) spectra of the top 10 most intense peaks were obtained by higher-
energy collisional dissociation fragmentation. Resolution for the MS/MS
spectra was 35,000 at 200 mz1, AGC target to 5E5.
Cell Culture and Proteomics Analysis
Validated cell lines were regularly tested for mycoplasms using a commercial
kit (VENOR, Sigma). Human podocytes (Saleem et al., 2002) were cultured in
dishes as described previously at 33C (Rinschen et al., 2016a). They were
seeded on collagen-coated soft matrices (Matrigen) for 2 days (passageCell Reports 23, 2495–2508, May 22, 2018 2505
20). Similarly, mouse podocytes (at 33C) (Griffin et al., 2004) were cultured in
coated Primaria cell culture dishes (Falcon) as described previously and
seeded on collagen-coated soft matrices (Matrigen) for 2 days. For details
regarding sample preparation, proteomics, and bioinformatics analysis, see
the Supplemental Experimental Procedures.
Pulsed In Vivo Stable Isotope Labeling
Stable isotope labeling of animals was performed as described previously by
Kr€uger et al. (2008). The Lys(0)-stable isotope labeling by amino acid in cell cul-
ture (SILAC)-Mouse control (12C6-lysine, ‘‘light’’) and Lys(6)-SILAC-Mouse SI-
LAC (13C6-lysine, 97%, ‘‘heavy’’) mouse diets were purchased from Silantes
(Martinsried, Germany). For details regarding sample preparation and prote-
omics of in vivo stable isotope-labeled tissue, see the Supplemental Experi-
mental Procedures.
Statistics
For quantitative data, statistical tests (two tailed unpaired t test, Kolmogorov-
Smirnov test, and two-way ANOVA test) were performed where appropriate
and where indicated. In general, p < 0.05 was considered significant. For
large-scale data, correction for multiple testing was performed as described
in the respective bioinformatics method sections.
Study Participants, Whole-Exome Sequencing, Multi-gene Panel
Testing, and Mutation Calling
We obtained blood samples and pedigrees following informed consent from
individuals with steroid resistant nephrotic syndrome (SRNS) or their legal
guardians. Approval for human subject research was obtained from the insti-
tutional review boards of the University of Michigan and Boston Children’s
Hospital. For details regarding whole-exome sequencing, multi-gene panel
testing, and mutation calling, see the Supplemental Experimental Procedures.
Model Organism Experiments
The detailed methods for functional analysis of zebrafish and Drosophila
proteinuric phenotypes as well as mouse in situ hybridization experiments
can be found in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and seven tables and can be found with this article online at
https://doi.org/10.1016/j.celrep.2018.04.059.
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